Top Markets
Coin of the day
Gujarat Themis Biosyn Ltd. Gujarat Themis Biosyn Ltd.

Gujarat Themis Biosyn Ltd.

GUJTHEM
Rank in Stocks #13246
Gujarat Themis Biosyn Ltd. is an Indian company primarily involved in the... Gujarat Themis Biosyn Ltd. is an Indian company primarily involved in the creation of pharmaceuticals and medicinal chemicals. The firm also supplies bulk drugs via a job work model within India. Its product offerings include important compounds such as Rifamycin-S, an intermediate used in treatments for tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease. Another key product, Rifamycin-O, addresses ailments like traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. Furthermore, they produce Lovastatin. Established in 1981, the company's operations are based out of Mumbai, India.
Share Price
$4.66
Market Cap
$507.71M
Change (1 day)
2.94%
Change (1 year)
8.43%
Country
IN
Trade Gujarat Themis Biosyn Ltd. (GUJTHEM)

Category

Revenue for Gujarat Themis Biosyn Ltd. (GUJTHEM)
Revenue in Aug 2026 TTM: 0
According to Gujarat Themis Biosyn Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Gujarat Themis Biosyn Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors